Making our Voices Heard at NCI

The Children's Cause Blog

On Friday February 21, the Children’s Cause for Cancer Advocacy (CCCA) was proud to participate in a full day meeting at the National Cancer Institute (NCI) with the Director’s Consumer Liaison Group (DCLG).  The entire day was devoted to barriers to drug development in pediatric cancer research — a first for this advisory board.  


The day began with  an overview of the state of pediatric cancer research, featuring top experts Dr. John Maris of the Children’s Hospital of Philadelphia,  Dr. Malcolm Smith and Dr. Lee Helman both of NCI.  All three speakers addressed both the significant progress we have made in certain childhood cancers and the fact that we have made virtually no progress in others.  When asked to specify the most promising advancements, we heard about unprecedented discoveries in recent years, particularly in immunotherapies.

Unfortunately though, there are still many challenges.

Among the challenges identified were:

  • The need…

View original post 372 more words

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s